Susquehanna Fundamental Investments, LLC Immunic, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $53,019 - $97,024	17,673 New	17,673 $56,000
Q2 2021 Aug 11, 2021	SELL	$11.76 - $16.85 $347,037 - $497,243	-29,510 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.21 - $25.3 $51,298 - $91,333	3,610 Added 13.94%	29,510 $470,000
Q4 2020 Feb 16, 2021	SELL	$14.8 - $20.37 $100,640 - $138,516	-6,800 Reduced 20.8%	25,900 $396,000
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $206,624 - $387,200	17,600 Added 116.56%	32,700 $607,000
Q2 2020 Aug 14, 2020	BUY	$5.67 - $15.86 $85,617 - $239,486	15,100 New	15,100 $183,000

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.6M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.